Eli Lilly Poised to Lead U.S. Obesity Drug Market
According to a recent report by BMO Capital Markets analysts, Eli Lilly & Co. (LLY) is well-positioned to dominate the ...
Tag: obesity drugs
Eli Lilly’s Earnings Report Could Boost Stock
Eli Lilly (LLY) has experienced significant growth in its stock this year, and its upcoming earnings report has the potential ...
